Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride
monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...
... of Product Characteristics; Print. TASIGNA (nilotinib) .... TASIGNA<sup>®</sup> (Nilotinib)
is approved for use in 110 countries around the world. Healthcare Professionals
Nilotinib | C28H22F3N7O | CID 644241 - structure, chemical names, physical
and chemical properties, classification, patents, literature, biological activities, ...
Oct 21, 2015 ... The NPF Recommends Further Study but Not Clinical Use of this Investigational
Drug. Tasigna (Nilotinib) is a leukemia drug that has recently ...
See full prescribing information for. TASIGNA. TASIGNA® (nilotinib) Capsules for
oral use. Initial U.S. Approval: 2007. WARNING: QT PROLONGATION AND ...
Nov 30, 2015 ... Learn about Tasigna Capsules (Nilotinib Capsules) may treat, uses, dosage, side
effects, drug interactions, warnings, patient labeling, reviews, ...
Jan 2, 2015 ... Read about the cancer treatment drug nilotinib, otherwise known as Tasigna,
including what it is, how it works and possible side effects.
(nye-LOE-ti-nib). Generic Name: nilotinib. Trade Name(s): Tasigna. Nilotinib is
the generic for the trade chemotherapy drug Tasigna. In some cases, health care
Easy to read patient leaflet for nilotinib. Includes indications, proper use, special
instructions, precautions, and possible side effects.
933 medications are known to interact with nilotinib. Includes Bayer Aspirin with
Heart Advantage (aspirin), Clexane (enoxaparin), Coumadin (warfarin).